ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near New Haven, CT, USA:

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

Stony Brook, New York, United States and 107 other locations

(IV) (Part 1) and subcutaneous (SC) (Part 2) doses of RO7121932 and multiple ascending SC (Part 3) doses of RO7121932 in participants with m ...

Enrolling
Multiple Sclerosis
Drug: RO7121932 - MAD
Drug: RO7121932 SC - SAD

Phase 1

Roche
Roche

New Haven, Connecticut, United States and 23 other locations

Locations recently updated

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Remibrutinib
Drug: Teriflunomide

Phase 3

Novartis
Novartis

Port Jefferson Station, New York, United States and 229 other locations

The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...

Enrolling
Relapsing Forms of Multiple Sclerosis
Drug: BIIB091
Drug: DRF

Phase 2

Biogen
Biogen

Patchogue, New York, United States of America and 73 other locations

Locations recently updated

The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...

Enrolling
Multiple Sclerosis
Drug: CC-97540
Drug: Cyclophosphamide

Phase 1

Juno Therapeutics

New Haven, Connecticut, United States and 34 other locations

for the overall conduct of the study at the site, confirmation of subject eligibility, routine study subject clinical management including for MS...

Active, not recruiting
Multiple Sclerosis
Drug: RPC-1063

Phase 3

Celgene
Celgene

East Setauket, New York, United States and 60 other locations

as a single IV bolus to subjects with known gadolinium-enhancing central nervous system (CNS) lesions (for example stable brain tumor or multiple...

Enrolling
Multiple Sclerosis Brain Lesion
Multiple Sclerosis
Drug: RVP-001

Phase 2

Reveal Pharmaceuticals

New Haven, Connecticut, United States and 3 other locations

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...

Active, not recruiting
Progressive Multiple Sclerosis (PMS)
Drug: Ocrelizumab

Phase 3

Roche
Roche

New Haven, Connecticut, United States and 125 other locations

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...

Enrolling
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo

Phase 3

Sanofi
Sanofi

East Setauket, New York, United States and 53 other locations

Phase 2/3, randomized, double-blind, placebo-controlled, single-treatment, multicenter trial assessing the efficacy and safety of MYOBLOC for the tre...

Active, not recruiting
Multiple Sclerosis
Cerebrovascular Accident
Drug: Phase 3; MYOBLOC
Drug: Phase 2; Placebo

Phase 2, Phase 3

Supernus Pharmaceuticals
Supernus Pharmaceuticals

Stamford, Connecticut, United States of America and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems